The Bioinformatics & Biotechnology Shared Resource provides a broad range of chemistry, biomolecular, and bioinformatics services and expertise in support of Cancer Center research programs. It includes six sections: Bioinformatics, High-throughput DNA Sequencing and Genotyping, Macromolecular Synthesis, Functional Genomics, Clinical Applications Core Technology (CACT), and Proteomics. Bioinformatics provides investigators with access to high-performance computing resources, bioinformatics software, and all major public biomolecular databases. Highthroughput DNA Sequencing & Genotyping provides investigators with access to automated DNA sequence analysis, fragment size analysis, and SNP detection technologies. Macromolecular Synthesis provides synthetic peptides and synthetic oligonucleotides to Cancer Center investigators (CCSG support is not be requested for this section). Functional Genomics provides cDNA microarray services and analyses to Center investigators. The Clinical Applications Core Technology section provides oligonucleotide-based microarray analysis (Affymetrix, Inc.) for investigators. (Functional Genomics and the CACT laboratory activities will be combined in this application). Proteomics offers a range of protein chemistry capabilities including protein sequence analysis using Edman chemistry, protein identification using mass spectrometry, and protein interaction analysis using surface plasmon resonance technology. All sections are highly integrated and readily accessible using our Web-based on-line ordering and tracking system and a comprehensive relational database system housing all chemistry information. The projected total budget for this Shared Resource in year-25 of this grant is $4,089,971 of which 12% ($498,763) is requested from the CCSG; the remainder of the budget (88%, $3,591,208) will be provided by SJCRH institutional funds and by chargeback to individual investigators. Over 80% of the usage of this Shared Resource is by Cancer Center members for peer-reviewed projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-25S1
Application #
6602679
Study Section
Project Start
2002-06-24
Project End
2007-02-28
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Dove, Austin P; Manole, Bogdan-Alexandru; Wakefield, Daniel V et al. (2018) Managing local-regional failure in children with high-risk neuroblastoma: A single institution experience. Pediatr Blood Cancer 65:e27408
Kurmasheva, Raushan T; Kurmashev, Dias; Reynolds, C Patrick et al. (2018) Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program. Pediatr Blood Cancer 65:
Chamdine, Omar; Elhawary, Ghada Ahmad Saad; Alfaar, Ahmad Samir et al. (2018) The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. Childs Nerv Syst 34:431-439
Heitzer, Andrew M; Ashford, Jason M; Harel, Brian T et al. (2018) Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma. J Neurooncol :
Robinson, Katherine M; Yang, Wenjian; Haidar, Cyrine E et al. (2018) Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies. Pharmacogenomics J :
Teitz, Tal; Fang, Jie; Goktug, Asli N et al. (2018) CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss. J Exp Med 215:1187-1203
Binder, Randall J; Hatfield, M Jason; Chi, Liying et al. (2018) Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors. Eur J Med Chem 149:79-89
Slayton, William B; Schultz, Kirk R; Kairalla, John A et al. (2018) Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622. J Clin Oncol 36:2306-2314
Donohoe, Clare; Bosi, Judy K; Sykes, April et al. (2018) Clinical Characteristics of Children and Adolescents Undergoing Hematopoietic Cell Transplantation Who Develop Oral Mucositis. Oncol Nurs Forum 45:457-462
Green, Daniel M; Wang, Mingjuan; Krasin, Matthew J et al. (2018) Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study. Hepatology :

Showing the most recent 10 out of 6764 publications